| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Non-Customized |
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
|
Product name |
Enzalutamide |
|
CAS No. |
915087-33-1 |
| Molecular Formula | C21H16F4N4O2S |
| Molecular Weight | 464.4359528 |
| Purity | 99% |
Enzalutamide is an androgen-receptor antagonist that blocks androgens from binding to the androgen receptor and prevents nuclear translocation and co-activator recruitment of the ligand-receptor complex. Enzalutamide has also been shown to induce tumor cell apoptosis, and has no agonist activity. Enzalutamide is a candidate for the treatment of castration-resistant prostate cancer.
Treatment of metastatic castration resistant prostate cancer. Research suggests that enzalutamide may also be effective in the treatment of certain types of breast cancer.
|
Product name
|
CAS No.
|
|
β-Nicotinamide Mononucleotide (NMN)
|
1094-61-7
|
|
beta-Diphosphopyridine nucleotide (NAD)
|
53-84-9
|
|
Nicotinamide riboside chloride (NRC)
|
23111-00-4
|
|
Nicotinamide Ribose (NR)
|
1341-23-7
|
|
|
53-43
|
Extraction process:
){kind=link}